These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36996255)

  • 1. Intracellular cGMP increase is not involved in thyroid cancer cell death.
    Alessandro S; Paradiso E; Lazzaretti C; Sperduti S; Perri C; Antoniani F; Righi S; Simoni M; Brigante G; Casarini L
    PLoS One; 2023; 18(3):e0283888. PubMed ID: 36996255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line.
    Limoncella S; Lazzaretti C; Paradiso E; D'Alessandro S; Barbagallo F; Pacifico S; Guerrini R; Tagliavini S; Trenti T; Santi D; Simoni M; Sola M; Di Rocco G; Casarini L
    Mol Cell Endocrinol; 2022 Feb; 542():111527. PubMed ID: 34875337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
    Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
    J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.
    Kim NN; Huang YH; Goldstein I; Bischoff E; Traish AM
    Life Sci; 2001 Sep; 69(19):2249-56. PubMed ID: 11669467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
    Fukuhara S; Tsujimura A; Okuda H; Yamamoto K; Takao T; Miyagawa Y; Nonomura N; Okuyama A
    J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
    Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and functional role of androgen-dependent PDE5 activity in the bladder.
    Filippi S; Morelli A; Sandner P; Fibbi B; Mancina R; Marini M; Gacci M; Vignozzi L; Vannelli GB; Carini M; Forti G; Maggi M
    Endocrinology; 2007 Mar; 148(3):1019-29. PubMed ID: 17138653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase type 5 inhibitors facilitate noncontact erections in male rats: site of action in the brain and mechanism of action.
    Sanna F; Succu S; Boi A; Melis MR; Argiolas A
    J Sex Med; 2009 Oct; 6(10):2680-9. PubMed ID: 19678884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors.
    Vignozzi L; Filippi S; Morelli A; Comeglio P; Cellai I; Sarchielli E; Maneschi E; Mancina R; Gacci M; Vannelli GB; Maggi M
    J Sex Med; 2012 Dec; 9(12):3028-40. PubMed ID: 23057807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
    Martínez-Salamanca JI; La Fuente JM; Cardoso J; Fernández A; Cuevas P; Wright HM; Angulo J
    J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
    Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
    J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
    Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
    Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
    Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
    J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity.
    Zoraghi R; Corbin JD; Francis SH
    J Biol Chem; 2006 Mar; 281(9):5553-8. PubMed ID: 16407275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of phosphodiesterase-5 is promoted by a conformational change induced by sildenafil, vardenafil, or tadalafil.
    Bessay EP; Zoraghi R; Blount MA; Grimes KA; Beasley A; Francis SH; Corbin JD
    Front Biosci; 2007 Jan; 12():1899-910. PubMed ID: 17127429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of PDE5 Inhibitors and the NO/cGMP Pathway in Cancer.
    Peak TC; Richman A; Gur S; Yafi FA; Hellstrom WJ
    Sex Med Rev; 2016 Jan; 4(1):74-84. PubMed ID: 27872007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues.
    Kashgari FK; Ravna A; Sager G; Lyså R; Enyedy I; Dietrichs ES
    Biomed Pharmacother; 2020 Jun; 126():110109. PubMed ID: 32229414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
    Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT
    J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vardenafil, an inhibitor of phosphodiesterase-5, blocks advanced glycation end product (AGE)-induced up-regulation of monocyte chemoattractant protein-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression via elevation of cGMP.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Clin Exp Med; 2011 Jun; 11(2):131-5. PubMed ID: 20803229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
    Aronsen L; Orvoll E; Lysaa R; Ravna AW; Sager G
    Eur J Pharmacol; 2014 Dec; 745():249-53. PubMed ID: 25445042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.